Patents by Inventor Lars Mouritsen

Lars Mouritsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MATERIALS AND METHODS FOR TREATING CANCER
    Publication number: 20210145830
    Abstract: This document provides methods for determining biological age of mammalian subjects or assessing whether the subjects are aging normally. Also provided herein are methods for determining whether therapeutic treatment or other interventions for reversing or slowing down aging are effective. This document also provides methods and materials for slowing the progression of biological aging.
    Type: Application
    Filed: April 5, 2019
    Publication date: May 20, 2021
    Inventors: Saad J. Kenderian, Neil E. Kay, Reona Sakemura, Steven L. Warner, David J. Bearss, Jason Marc Foulks, Lars Mouritsen, Clifford J. Whatcott
  • PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING
    Publication number: 20200200737
    Abstract: The present disclosure is generally directed to profiling peptides, compositions, and kits, as well as methods of use thereof. The profiling peptides comprise an Mcl-1 binding domain, and optionally a cellular uptake moiety. The methods of using such profiling peptides include predicting sensitivity of a cancer, selecting a treatment, treating a cancer, producing a sensitivity profile, and the like.
    Type: Application
    Filed: August 20, 2019
    Publication date: June 25, 2020
    Applicant: Tolero Pharmaceuticals, Inc.
    Inventors: David J. BEARSS, Adam SIDDIQUI-JAIN, Clifford J. WHATCOTT, Peter W. PETERSON, Steven L. WARNER, Lars MOURITSEN
  • Profiling peptides and methods for sensitivity profiling
    Patent number: 10422788
    Abstract: The present disclosure is generally directed to profiling peptides, compositions, and kits, as well as methods of use thereof. The profiling peptides comprise an Mcl-1 binding domain, and optionally a cellular uptake moiety. The methods of using such profiling peptides include predicting sensitivity of a cancer, selecting a treatment, treating a cancer, producing a sensitivity profile, and the like.
    Type: Grant
    Filed: February 19, 2019
    Date of Patent: September 24, 2019
    Assignee: TOLERO PHARMACEUTICALS, INC.
    Inventors: David J. Bearss, Adam Siddiqui-Jain, Clifford J. Whatcott, Peter W. Peterson, Steven L. Warner, Lars Mouritsen
  • PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING
    Publication number: 20190178873
    Abstract: The present disclosure is generally directed to profiling peptides, compositions, and kits, as well as methods of use thereof. The profiling peptides comprise an Mcl-1 binding domain, and optionally a cellular uptake moiety. The methods of using such profiling peptides include predicting sensitivity of a cancer, selecting a treatment, treating a cancer, producing a sensitivity profile, and the like.
    Type: Application
    Filed: February 19, 2019
    Publication date: June 13, 2019
    Inventors: David J. BEARSS, Adam Siddiqui-Jain, Clifford J. Whatcott, Peter W. Peterson, Steven L. Warner, Lars Mouritsen
  • Profiling peptides and methods for sensitivity profiling
    Patent number: 10267787
    Abstract: The present disclosure is generally directed to profiling peptides, compositions, and kits, as well as methods of use thereof. The profiling peptides comprise an Mcl-1 binding domain, and optionally a cellular uptake moiety. The methods of using such profiling peptides include predicting sensitivity of a cancer, selecting a treatment, treating a cancer, producing a sensitivity profile, and the like.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: April 23, 2019
    Assignee: Tolero Pharmaceuticals, Inc.
    Inventors: David J. Bearss, Adam Siddiqui-Jain, Clifford J. Whatcott, Peter W. Peterson, Steven L. Warner, Lars Mouritsen
  • Profiling peptides and methods for sensitivity profiling
    Patent number: 10132797
    Abstract: The present disclosure is generally directed to profiling peptides, compositions, and kits, as well as methods of use thereof. The profiling peptides comprise an Mcl-1 binding domain, and optionally a cellular uptake moiety. The methods of using such profiling peptides include predicting sensitivity of a cancer, selecting a treatment, treating a cancer, producing a sensitivity profile, and the like.
    Type: Grant
    Filed: December 19, 2017
    Date of Patent: November 20, 2018
    Assignee: Tolero Pharmaceuticals, Inc.
    Inventors: David J. Bearss, Adam Siddiqui-Jain, Clifford J. Whatcott, Peter W. Peterson, Steven L. Warner, Lars Mouritsen
  • PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING
    Publication number: 20180299432
    Abstract: The present disclosure is generally directed to profiling peptides, compositions, and kits, as well as methods of use thereof. The profiling peptides comprise an Mcl-1 binding domain, and optionally a cellular uptake moiety. The methods of using such profiling peptides include predicting sensitivity of a cancer, selecting a treatment, treating a cancer, producing a sensitivity profile, and the like.
    Type: Application
    Filed: June 29, 2018
    Publication date: October 18, 2018
    Inventors: David J. Bearss, Adam Siddiqui-Jain, Clifford J. Whatcott, Peter W. Peterson, Steven L. Warner, Lars Mouritsen
  • PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING
    Publication number: 20180172673
    Abstract: The present disclosure is generally directed to profiling peptides, compositions, and kits, as well as methods of use thereof. The profiling peptides comprise an Mcl-1 binding domain, and optionally a cellular uptake moiety. The methods of using such profiling peptides include predicting sensitivity of a cancer, selecting a treatment, treating a cancer, producing a sensitivity profile, and the like.
    Type: Application
    Filed: December 19, 2017
    Publication date: June 21, 2018
    Inventors: David J. Bearss, Adam Siddiqui-Jain, Clifford J. Whatcott, Peter W. Peterson, Steven L. Warner, Lars Mouritsen